149 related items for PubMed ID: 35929901
1. Normal ambulatory blood pressure in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH, Camargo DA, Sewaybricker LE, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra G, Gonçalves EM.
Arch Endocrinol Metab; 2023 Jan 18; 67(1):64-72. PubMed ID: 35929901
[Abstract] [Full Text] [Related]
2. 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report.
de Silva KS, Kanumakala S, Brown JJ, Jones CL, Warne GL.
J Pediatr Endocrinol Metab; 2004 Aug 18; 17(8):1089-95. PubMed ID: 15379420
[Abstract] [Full Text] [Related]
3. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
Clin Endocrinol (Oxf); 2003 May 18; 58(5):589-96. PubMed ID: 12699440
[Abstract] [Full Text] [Related]
4. Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM.
Osteoporos Int; 2022 Jan 18; 33(1):283-291. PubMed ID: 34406442
[Abstract] [Full Text] [Related]
5. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
6. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Paizoni L, Auer MK, Schmidt H, Hübner A, Bidlingmaier M, Reisch N.
J Steroid Biochem Mol Biol; 2020 Mar 19; 197():105540. PubMed ID: 31730799
[Abstract] [Full Text] [Related]
7. Cardiovascular dysfunction risk in young adults with congenital adrenal hyperplasia caused by 21-hydroxylase enzyme deficiency.
Borges JH, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM.
Int J Clin Pract; 2021 Jul 19; 75(7):e14233. PubMed ID: 33884716
[Abstract] [Full Text] [Related]
8. Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Dötsch J, Rascher W, Dörr HG.
J Clin Endocrinol Metab; 2006 Dec 19; 91(12):4888-95. PubMed ID: 17003094
[Abstract] [Full Text] [Related]
9. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N, Atabek ME, Eklioğlu BS, Alp H.
J Clin Res Pediatr Endocrinol; 2015 Mar 19; 7(1):13-8. PubMed ID: 25800471
[Abstract] [Full Text] [Related]
10. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study.
Stergiou GS, Alamara C, Drakatos A, Stefanidis CJ, Vazeou A.
Hypertens Res; 2009 Aug 19; 32(8):680-4. PubMed ID: 19498440
[Abstract] [Full Text] [Related]
11. Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia.
Espinosa Reyes TM, Pesántez Velepucha AK, Cabrera Rego JO, Valdés Gómez W, Domínguez Alonso E, Falhammar H.
BMC Endocr Disord; 2023 Nov 02; 23(1):241. PubMed ID: 37919699
[Abstract] [Full Text] [Related]
12. Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Hoepffner W, Herrmann A, Willgerodt H, Keller E.
J Pediatr Endocrinol Metab; 2006 May 02; 19(5):705-11. PubMed ID: 16789637
[Abstract] [Full Text] [Related]
13. Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia.
Navardauskaite R, Semeniene K, Sukys M, Pridotkaite A, Vanckaviciene A, Zilaitiene B, Verkauskiene R.
Medicina (Kaunas); 2022 Mar 30; 58(4):. PubMed ID: 35454339
[Abstract] [Full Text] [Related]
14. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y, Asmar R.
Am J Hypertens; 1999 Dec 30; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[Abstract] [Full Text] [Related]
15. A 15-year longitudinal study on ambulatory blood pressure tracking from childhood to early adulthood.
Li Z, Snieder H, Harshfield GA, Treiber FA, Wang X.
Hypertens Res; 2009 May 30; 32(5):404-10. PubMed ID: 19325561
[Abstract] [Full Text] [Related]
16. Steroid responsive hypertension secondary to 11-beta hydroxylase deficiency--a case report.
Isiavwe AR, Ekpebegh CO, Fasanmade OA, Ohwovoriole AE.
West Afr J Med; 2008 Jul 30; 27(3):182-5. PubMed ID: 19256327
[Abstract] [Full Text] [Related]
17. Fat Distribution and Lipid Profile of Young Adults with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Enzyme Deficiency.
Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Gonçalves EM, Guerra-Júnior G.
Lipids; 2021 Jan 30; 56(1):101-110. PubMed ID: 32929736
[Abstract] [Full Text] [Related]
18. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
Endokrynol Pol; 2010 Jan 30; 61 Suppl 1():7-21. PubMed ID: 22127631
[Abstract] [Full Text] [Related]
19. Diurnal rhythm of blood pressure among Nigerians with hypertension using 24-hour ambulatory blood pressure monitoring.
Amjo I, Adebayo RA, Akinyele OA, Olanipekun OA, Adesanya OS, Williams OT, Ogunyemi SA, Akintomide AO, Ajayi OE, Balogun MO, Oguntola BO, Akhionbare IG, Adebiyi LO.
Pan Afr Med J; 2020 Jan 30; 36():240. PubMed ID: 33708331
[Abstract] [Full Text] [Related]
20. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 30; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
